Pancreatic Cancer Research

ResearcherHumboldt-Universität zu BerlinNo recent work listed

Josefina Doffo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5022321220. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Co-author DOI 10.1073/pnas.2105691119↗
  2. Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC. Co-author DOI 10.1002/1878-0261.12835↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ulrich Bernd Keller · 2 shared papers, 2020–2022 · strength 0.22
  2. Maximilian Reichert · 2 shared papers, 2020–2022 · strength 0.22
  3. Oliver Holger Krämer · 2 shared papers, 2020–2022 · strength 0.22
  4. Günter Schneider · 2 shared papers, 2020–2022 · strength 0.22
  5. Matthias Wirth · 2 shared papers, 2020–2022 · strength 0.22
  6. Felix Orben · 1 shared paper, 2022 · strength 0.12
  7. Elmar Wolf · 1 shared paper, 2022 · strength 0.12
  8. Hazal Köse · 1 shared paper, 2022 · strength 0.12
  9. Iréne Esposito · 1 shared paper, 2022 · strength 0.12
  10. Katharina Lankes · 1 shared paper, 2020 · strength 0.10
  11. Christian Schneeweis · 1 shared paper, 2020 · strength 0.10
  12. Zonera Hassan · 1 shared paper, 2020 · strength 0.10
  13. Roland Rad · 1 shared paper, 2020 · strength 0.10
  14. Dieter Saur · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.